about
Differential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemiaImproved nTMS- and DTI-derived CST tractography through anatomical ROI seeding on anterior pontine level compared to internal capsule.The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[(18)F]fluoroethyl)-L-tyrosine (FET).O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.Clinical value of 2-deoxy-[18F]fluoro-D-glucose positron emission tomography in patients with cervical spondylotic myelopathy.Isomers of 4-[18F]fluoro-proline: radiosynthesis, biological evaluation and results in humans using PET.Spatial Relationship of Glioma Volume Derived from FET PET and Volumetric MRSI: a hybrid PET-MRI study.O-(2-[18F]fluoroethyl)-L-tyrosine PET in gliomas: influence of data processing in different centres.Functional MRI vs. navigated TMS to optimize M1 seed volume delineation for DTI tractography. A prospective study in patients with brain tumours adjacent to the corticospinal tract.Uptake of O-(2-[18F]fluoroethyl)-L-tyrosine in reactive astrocytosis in the vicinity of cerebral gliomas.Congruency of tumour volume delineated by FET PET and MRSI.Radiation injury vs. recurrent brain metastasis: combining textural feature radiomics analysis and standard parameters may increase 18F-FET PET accuracy without dynamic scans.Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET.Dual-time-point O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas.5-Aminolevulinic Acid and (18)F-FET-PET as Metabolic Imaging Tools for Surgery of a Recurrent Skull Base Meningioma.Adapting MR-BrainPET scans for comparison with conventional PET: experiences with dynamic FET-PET in brain tumours.Regional impairment of 18F-FDG uptake in the cervical spinal cord in patients with monosegmental chronic cervical myelopathy.Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.Monitoring of radiochemotherapy in patients with glioblastoma using O-(2-¹⁸Fluoroethyl)-L-tyrosine positron emission tomography: is dynamic imaging helpful?Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.High resolution BrainPET combined with simultaneous MRI.Evaluation of factors influencing 18F-FET uptake in the brain.PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors: first clinical results.Prognostic value of 18F-FDG PET in monosegmental stenosis and myelopathy of the cervical spinal cord.cis-4-[(18)F]-Fluoro-l-proline fails to detect peripheral tumors in humans.Evaluation of new 18F-labeled amino acids for brain PET.Earlier diagnosis of progressive disease during bevacizumab treatment using O-(2-18F-fluorethyl)-L-tyrosine positron emission tomography in comparison with magnetic resonance imaging.[Improved diagnostics of cerebral gliomas using FET PET].Differential uptake of O-(2-18F-fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscesses.Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors.Multimodal imaging utilising integrated MR-PET for human brain tumour assessment.Static and dynamic 18F-FET PET for the characterization of gliomas defined by IDH and 1p/19q status.Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease.Multimodal Imaging in Malignant Brain Tumors: Enhancing the Preoperative Risk Evaluation for Motor Deficits with a Combined Hybrid MRI-PET and Navigated Transcranial Magnetic Stimulation Approach.Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.Comparison of 18F-FET PET and perfusion-weighted MRI for glioma grading: a hybrid PET/MR study.Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.
P50
Q28275612-6C8C9D56-A915-4569-9016-1CD1DE58C96BQ35040773-ECE63440-266A-44BE-81ED-F4A6546D577CQ36107374-ED08FE8E-F329-4CCD-BCBF-3DA498C120F8Q36383638-22341E22-D20B-447F-9F19-2A2760E4EBDCQ36456309-05EEB9DD-AFB5-4FFC-941A-7459201ED57EQ37037922-1028D6B2-C275-4FE7-99B0-04825B2B387CQ38118352-A35026D6-B562-4189-9182-9D3A0702E93EQ38245654-0BB24557-CC08-436D-8F80-F10F01EC7891Q38605118-74C3F43B-A7CF-4B45-8D0C-2BC303073636Q38620991-353E80E1-E163-4C0F-B2F2-01C800BF8C11Q39041938-A4DF2E71-5D68-44C2-906A-72B4DD2CB48FQ39139452-332CCCBF-2CF7-4A0A-BEEC-774A30C7EC60Q39180347-63112439-A794-44F7-9A7A-FF42F1447F62Q39181712-69182B03-82C0-49A8-A02D-02AABEA42053Q41045513-94EE3AF0-593F-42F6-B7BC-75E573DE0C02Q41154181-62050222-F91A-4ED7-87B6-DC86D4F8F41FQ41827530-32479D6C-188B-4812-A817-B6290BBC952AQ42137779-8B8ED73A-BA3A-48C2-881C-C618523A4AA2Q42965031-D0FC8612-F0BC-4909-BE13-F6E819D557AEQ43282984-063ADCB1-1F2D-40C9-A27C-10DAFF65EE1FQ43699515-BD927A6B-0F8C-4CF5-9EC0-69E9770D0CF6Q44314553-BB4C8E92-DD92-4A1F-B081-1A33FB7E476CQ44461998-1BA1B3CD-6B62-4C67-BFFB-2DF3B0FBA7A8Q44789206-933A42C7-DFEE-4689-9D25-FADFBDB7E106Q44799557-DBAA9098-BAC6-4838-B2C0-6F3965FF4DCAQ45305168-DE935060-F743-4D8C-AD57-0AB1E3A8850DQ45833326-93D20392-4BF5-47A0-B3B5-82ED41A080B4Q46232924-5C494FC8-567F-4B84-BF77-E70BA01077BEQ46715612-ED7078C2-0A98-4BBF-AC8F-D4F4FBAF5909Q46722538-99A3439A-25BF-4986-B2D3-9FC5583F99ACQ46768751-EA882305-4805-4418-98F0-E44DA9925D97Q46897732-6700EF56-E9BF-45FF-AFC2-75E78515C7F4Q46922149-889E8FCB-DAEB-422C-B848-DEFA8665578BQ47402888-1FC246FA-772B-4469-958F-CD87514390C7Q47771695-3B0EFA19-8E94-43A0-B6A9-DC7953F9DFDEQ48015053-9D8F5087-DAB2-49C6-9269-B86E05C18E00Q48112128-E1E3DEEE-D478-4943-B2D9-FE34A3C1A64BQ48118487-A7671E97-F9C8-4457-B8C5-FB6B261EF135Q48143872-8F94C85A-2A93-49D5-B73B-695BB01FD4D6Q48221556-7374234F-444B-4860-9AF2-A0D496FE7F1B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gabriele Stoffels
@ast
Gabriele Stoffels
@en
Gabriele Stoffels
@es
Gabriele Stoffels
@nl
type
label
Gabriele Stoffels
@ast
Gabriele Stoffels
@en
Gabriele Stoffels
@es
Gabriele Stoffels
@nl
prefLabel
Gabriele Stoffels
@ast
Gabriele Stoffels
@en
Gabriele Stoffels
@es
Gabriele Stoffels
@nl
P106
P31
P496
0000-0001-7114-1941